Literature DB >> 30637726

Aucubin inhibits IL-1β- or TNF-α-induced extracellular matrix degradation in nucleus pulposus cell through blocking the miR-140-5p/CREB1 axis.

Shaofeng Yang1, Linghui Li2, Liguo Zhu2, Chao Zhang1, Zhaoyong Li1, Yantao Guo1, Ying Nie1, Zhenhua Luo1.   

Abstract

In intervertebral disc degeneration (IDD), increased proinflammatory molecules secreted by human nucleus pulposus cells (HNPCs) could promote the expression of extracellular matrix (ECM)-degrading enzymes. IDD could be affected by both genetic and environmental factors, including microRNAs (miRNAs). Aucubin, the active ingredient of a traditional Chinese medicine herb Du Zhong, has been reported to promote osteogenic differentiation; however, the role of aucubin in IDD and the underlying mechanism remain unclear. Herein, we evaluated the effect of aucubin on TNF-α- or IL-1β-induced ECM degradation in HNPCs. By using online tools, miR-140 was selected as a candidate miRNA that is related to TNF-α or IL-1β signaling. Overexpression of miR-140 enhanced the effect of aucubin on ECM degradation. Moreover, cAMP responsive element binding protein 1 (CREB1), a major transcriptional factor in immune-related signaling, was a direct downstream target of miR-140. CREB1 knockdown mimicked the function of miR-140 overexpression on ECM degradation. In summary, aucubin might ameliorate IL-1β- or TNF-α-induced ECM degradation in HNPCs through regulating miR-140/CREB1.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  IL-1β; TNF-α; aucubin; cAMP responsive element binding protein 1; intervertebral disc degeneration; miR-140

Mesh:

Substances:

Year:  2019        PMID: 30637726     DOI: 10.1002/jcp.28044

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Long noncoding RNA XIST modulates microRNA-135/CREB1 axis to influence osteogenic differentiation of osteoblast-like cells in mice with tibial fracture healing.

Authors:  Ying Zhang; Qiang Yuan; Qiushi Wei; Peifeng Li; Zhikun Zhuang; Jitian Li; Youwen Liu; Leilei Zhang; Zhinan Hong; Wei He; Haibin Wang; Wuyin Li
Journal:  Hum Cell       Date:  2021-10-11       Impact factor: 4.174

2.  Deep Sequencing of Serum Exosomal microRNA Level in Psoriasis Vulgaris Patients.

Authors:  Xiu-Min Chen; Dan-Ni Yao; Mao-Jie Wang; Xiao-Dong Wu; Jing-Wen Deng; Hao Deng; Run-Yue Huang; Chuan-Jian Lu
Journal:  Front Med (Lausanne)       Date:  2022-05-19

3.  Interleukin-1β and cathepsin D modulate formation of the terminal complement complex in cultured human disc tissue.

Authors:  Graciosa Q Teixeira; Zhiyao Yong; Amelie Kuhn; Jana Riegger; Raquel M Goncalves; Michael Ruf; Uwe M Mauer; Markus Huber-Lang; Anita Ignatius; Rolf E Brenner; Cornelia Neidlinger-Wilke
Journal:  Eur Spine J       Date:  2021-06-24       Impact factor: 3.134

4.  MicroRNA-140-3p alleviates intervertebral disc degeneration via KLF5/N-cadherin/MDM2/Slug axis.

Authors:  Zhenyu Wang; Shaokun Zhang; Yuguang Zhao; Zhigang Qu; Xinming Zhuang; Qingxu Song; Jiali Leng; Yi Liu
Journal:  RNA Biol       Date:  2021-04-27       Impact factor: 4.652

5.  LIPUS inhibits inflammation and catabolism through the NF-κB pathway in human degenerative nucleus pulposus cells.

Authors:  Weiwei Yi; Qing Chen; Dawu Wang; Dingqun Bai; Chuan Liu; Kaiting Li; Bailong Tao; Guihua Tian; Lu Zhou; Xiaohong Li; Jieliang Shen; Bo Liu; Zhenming Hu
Journal:  J Orthop Surg Res       Date:  2021-10-18       Impact factor: 2.359

Review 6.  Role of microRNAs in intervertebral disc degeneration (Review).

Authors:  Fengguang Yang; Jizu Wang; Zhixin Chen; Yuping Yang; Wenhui Zhang; Shifang Guo; Qingshan Yang
Journal:  Exp Ther Med       Date:  2021-06-10       Impact factor: 2.447

7.  MiR-423-5p Regulates Cells Apoptosis and Extracellular Matrix Degradation via Nucleotide-Binding, Leucine-Rich Repeat Containing X1 (NLRX1) in Interleukin 1 beta (IL-1β)-Induced Human Nucleus Pulposus Cells.

Authors:  Hanrong Xu; Liefeng Ji; Chunhua Yu; Qiming Chen; Qiangqiang Ge; Yinjiang Lu
Journal:  Med Sci Monit       Date:  2020-05-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.